1. Home
  2. RDY vs JHX Comparison

RDY vs JHX Comparison

Compare RDY & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • JHX
  • Stock Information
  • Founded
  • RDY 1984
  • JHX 1888
  • Country
  • RDY India
  • JHX Ireland
  • Employees
  • RDY N/A
  • JHX N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • JHX Building Materials
  • Sector
  • RDY Health Care
  • JHX Industrials
  • Exchange
  • RDY Nasdaq
  • JHX Nasdaq
  • Market Cap
  • RDY 11.6B
  • JHX 11.8B
  • IPO Year
  • RDY N/A
  • JHX N/A
  • Fundamental
  • Price
  • RDY $13.88
  • JHX $16.72
  • Analyst Decision
  • RDY Strong Buy
  • JHX Strong Buy
  • Analyst Count
  • RDY 1
  • JHX 9
  • Target Price
  • RDY $16.90
  • JHX $28.00
  • AVG Volume (30 Days)
  • RDY 1.1M
  • JHX 5.9M
  • Earning Date
  • RDY 10-24-2025
  • JHX 11-18-2025
  • Dividend Yield
  • RDY 0.51%
  • JHX N/A
  • EPS Growth
  • RDY 9.95
  • JHX N/A
  • EPS
  • RDY 0.79
  • JHX 0.77
  • Revenue
  • RDY $3,851,623,984.00
  • JHX $3,785,500,000.00
  • Revenue This Year
  • RDY $6.29
  • JHX $21.70
  • Revenue Next Year
  • RDY $2.61
  • JHX $16.85
  • P/E Ratio
  • RDY $17.55
  • JHX $29.56
  • Revenue Growth
  • RDY 14.10
  • JHX N/A
  • 52 Week Low
  • RDY $12.26
  • JHX $16.60
  • 52 Week High
  • RDY $16.17
  • JHX $37.65
  • Technical
  • Relative Strength Index (RSI)
  • RDY 49.14
  • JHX 23.71
  • Support Level
  • RDY $13.37
  • JHX $16.64
  • Resistance Level
  • RDY $13.52
  • JHX $17.50
  • Average True Range (ATR)
  • RDY 0.24
  • JHX 0.61
  • MACD
  • RDY 0.02
  • JHX -0.47
  • Stochastic Oscillator
  • RDY 49.31
  • JHX 1.99

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About JHX James Hardie Industries plc (Ireland)

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.

Share on Social Networks: